tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AXSM Stock Latest News

Axsome Therapeutics enters $570M term loan, revolving credit facility
The FlyAxsome Therapeutics enters $570M term loan, revolving credit facility
33m ago
BX
AXSM
Axsome Therapeutics Secures $570M Loan with Blackstone
PremiumCompany Announcements
Axsome Therapeutics Secures $570M Loan with Blackstone
35m ago
8K
AXSM
Axsome Therapeutics price target lowered to $180 from $200 at H.C. Wainwright
PremiumThe Fly
Axsome Therapeutics price target lowered to $180 from $200 at H.C. Wainwright
6d ago
AXSM
Strong Buy Rating for Axsome Therapeutics Driven by Product Performance and Pipeline Progress
PremiumRatings
Strong Buy Rating for Axsome Therapeutics Driven by Product Performance and Pipeline Progress
6d ago
AXSM
Axsome Therapeutics price target raised to $176 from $174 at BofA
PremiumThe Fly
Axsome Therapeutics price target raised to $176 from $174 at BofA
7d ago
AXSM
Axsome Therapeutics price target raised to $162 from $160 at Baird
PremiumThe FlyAxsome Therapeutics price target raised to $162 from $160 at Baird
7d ago
AXSM
Axsome Therapeutics price target raised to $165 from $160 at Wells Fargo
Premium
The Fly
Axsome Therapeutics price target raised to $165 from $160 at Wells Fargo
7d ago
AXSM
Axsome Therapeutics: Strong Market Performance and Promising Growth Potential with Key Catalysts Ahead
Premium
Ratings
Axsome Therapeutics: Strong Market Performance and Promising Growth Potential with Key Catalysts Ahead
7d ago
AXSM
Axsome Therapeutics: Strong Growth Potential with Auvelity’s Market Expansion and Strategic Initiatives
PremiumRatings
Axsome Therapeutics: Strong Growth Potential with Auvelity’s Market Expansion and Strategic Initiatives
7d ago
AXSM
Axsome Therapeutics Reports Strong Q1 2025 Growth
PremiumCompany Announcements
Axsome Therapeutics Reports Strong Q1 2025 Growth
7d ago
AXSM
Axsome Therapeutics’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Axsome Therapeutics’ Earnings Call Highlights Growth and Challenges
7d ago
AXSM
Morning Movers: Skechers surges following take-private deal
PremiumThe Fly
Morning Movers: Skechers surges following take-private deal
8d ago
HHH
SKX
Axsome Therapeutics reports Q1 EPS ($1.22), consensus ($1.35)
PremiumThe FlyAxsome Therapeutics reports Q1 EPS ($1.22), consensus ($1.35)
8d ago
AXSM
Axsome Therapeutics expects cash to fund operations into cash flow positivity
Premium
The Fly
Axsome Therapeutics expects cash to fund operations into cash flow positivity
8d ago
AXSM
AXSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AXSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
10d ago
AXSM
Axsome Therapeutics, Mental Health America partner for Mental Health Month
PremiumThe Fly
Axsome Therapeutics, Mental Health America partner for Mental Health Month
12d ago
AXSM
Axsome Therapeutics price target raised to $193 from $190 at RBC Capital
PremiumThe Fly
Axsome Therapeutics price target raised to $193 from $190 at RBC Capital
14d ago
AXSM
Positive Outlook on Axsome Therapeutics Driven by Auvelity’s Strong Commercial Performance
PremiumRatings
Positive Outlook on Axsome Therapeutics Driven by Auvelity’s Strong Commercial Performance
15d ago
AXSM
Positive Outlook on Axsome Therapeutics’ AXS-12 for Narcolepsy Treatment Amid Promising Phase III Results
PremiumRatings
Positive Outlook on Axsome Therapeutics’ AXS-12 for Narcolepsy Treatment Amid Promising Phase III Results
29d ago
AXSM
Seeking Recession-Proof Stocks? RBC Suggests 2 Healthcare Stocks to Buy
PremiumStock Analysis & IdeasSeeking Recession-Proof Stocks? RBC Suggests 2 Healthcare Stocks to Buy
1M ago
ALNY
AXSM
William Blair healthcare analysts hold an analyst/industry conference call
Premium
The Fly
William Blair healthcare analysts hold an analyst/industry conference call
1M ago
AXSM
Promising Developments in Axsome Therapeutics’ AXS-12 Bolster Buy Rating
Premium
Ratings
Promising Developments in Axsome Therapeutics’ AXS-12 Bolster Buy Rating
1M ago
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >